TickerFacts.

OneMedNet Corp (ONMD): Capital Expenditures

Annual figures by period end, from SEC filings.

$13.0K
Year ended 2025-12-31
$16.0K
Trailing 12 months to 2026-06-30
-39.3%
3-year compound annual growth
$58.0K2022-12-31: $58.0K2023-12-31: $44.0K2024-12-31: $51.0K2025-12-31: $13.0K$13.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$13.0K-74.5%2026-03-30, From 2025-01-01
2024-12-31$51.0K+15.9%2026-03-30, From 2024-01-01
2023-12-31$44.0K-24.1%2025-04-15, From 2023-01-01
2022-12-31$58.0Kn/a2024-11-05, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
OneMedNet Corp (ONMD)2025-12-31$13.0K-74.5%
iSpecimen Inc. (ISPC)2025-12-31$454-98.6%
Absci Corp (ABSI)2025-12-31$1.11M+174.0%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$60.6K-23.4%
Foxo Technologies Inc. (FOXO)2025-12-31$62.0Kn/a
OmniAb, Inc. (OABI)2025-12-31$565.0K-69.9%
MaxCyte, Inc. (MXCT)2025-12-31$1.77M+7.1%
NRC Health (NRC)2025-12-31$10.71M-30.7%
Medpace Holdings, Inc. (MEDP)2025-12-31$31.36M-14.2%

Compare ONMD, ISPC, ABSI, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗